JANX Janux Therapeutics, Inc.

Fundamentals / CIK 0001817713 / USD

Janux Therapeutics, Inc. reported $23.29M in revenue and a net loss of $99.85M for the trailing twelve months ended September 30, 2026 (down 7.1% year over year), with a -599.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open JANX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$22.43M$11.22M$0-$107.1MFY 2020 Revenue: $0FY 2020 Net Income: -$6.78M2020FY 2021 Revenue: $3.64MFY 2021 Net Income: -$32.67M2021FY 2022 Revenue: $8.61MFY 2022 Net Income: -$63.06M2022FY 2023 Revenue: $8.08MFY 2023 Net Income: -$58.29M2023FY 2024 Revenue: $10.59MFY 2024 Net Income: -$68.99M2024FY 2025 Revenue: $10.00MFY 2025 Net Income: -$113.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $10.00M $10.59M $8.08M $8.61M $3.64M $0
Research & Development $125.9M $68.39M $54.92M $53.44M $26.24M $3.04M
Operating Income -$157.7M -$98.85M -$72.98M -$67.09M -$32.93M -$4.84M
EBITDA -$155.6M -$96.79M -$71.02M -$66.25M -$32.82M -$4.83M
Income Tax Expense $0 $0 $0 -- -- --
Net Income -$113.6M -$68.99M -$58.29M -$63.06M -$32.67M -$6.78M
Basic EPS -$1.83 -$1.28 -$1.32 -$1.52 -$1.39 -$5.78
Diluted EPS -$1.83 -$1.28 -$1.32 -$1.52 -$1.39 -$5.78
Basic Shares Outstanding 62.0M 53.8M 44.0M 41.5M 23.5M 299.4K
Diluted Shares Outstanding 62.0M 53.8M 44.0M 41.5M 23.5M 1.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.29M $10.27M $3.73M $0 $10.00M $0 $0 $0
Research & Development $30.57M $30.99M $26.81M $31.55M $34.63M $34.66M $25.05M $20.81M
Operating Income -$31.26M -$31.69M -$34.21M -$42.40M -$35.25M -$45.12M -$34.90M -$29.02M
EBITDA -$30.80M -$31.23M -$33.74M -$41.93M -$34.75M -$44.58M -$34.38M -$28.51M
Net Income -$21.57M -$21.97M -$24.36M -$31.95M -$24.31M -$33.86M -$23.51M -$20.22M
Basic EPS -$0.34 -$0.35 -$0.39 -- -$0.39 -$0.55 -$0.38 --
Diluted EPS -$0.34 -$0.35 -$0.39 -- -$0.39 -$0.55 -$0.38 --
Basic Shares Outstanding 63.1M 62.9M 62.7M -- 62.0M 61.9M 61.8M --
Diluted Shares Outstanding 63.1M 62.9M 62.7M -- 62.0M 61.9M 61.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $52.33M $430.6M $19.20M $51.43M $35.58M $7.81M
Short-Term Investments $914.2M $594.6M $324.8M $275.6M $339.4M $0
Cash & Short-Term Investments $966.6M $1.03B $344.0M $327.0M $375.0M $7.81M
Accounts Receivable, Net $0 -- $0 $0 $0 $8.00M
Total Current Assets $975.9M $1.03B $349.2M $332.4M $377.0M $16.06M
Property, Plant & Equipment, Net $3.85M $4.86M $7.00M $7.09M $1.41M $155K
Other Non-Current Assets $2.61M $2.88M $2.51M $1.39M $392K $0
Total Non-Current Assets $25.68M $27.85M $31.17M $31.57M $2.81M $155K
Total Assets $1.00B $1.06B $380.4M $364.0M $379.8M $16.22M
Accounts Payable $4.97M $4.03M $2.42M $2.16M $2.46M $428K
Deferred Revenue (Current) $0 $0 $1.71M $5.41M $5.16M $1.95M
Total Current Liabilities $25.00M $17.46M $13.03M $16.51M $12.80M $3.18M
Deferred Revenue (Non-Current) $0 -- $0 $2.22M $700K $6.05M
Total Non-Current Liabilities $19.75M $21.28M $23.02M $26.76M $700K $6.05M
Total Liabilities $44.74M $38.73M $36.06M $43.27M $13.50M $9.23M
Total Debt (incl. Leases) $22.14M $23.02M $24.54M $25.30M $194K --
Common Stock $60K $59K $46K $42K $41K $1.0K
Retained Earnings -$351.4M -$237.8M -$168.8M -$110.5M -$47.41M -$14.74M
Accumulated Other Comp. Income $4.32M $2.16M $665K -$1.53M -$270K $0
Total Stockholders' Equity $956.8M $1.02B $344.3M $320.7M $366.3M -$14.64M
Total Equity $956.8M $1.02B $344.3M $320.7M $366.3M -$14.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $41.82M $27.77M $51.83M $52.33M $48.39M $52.45M $73.74M $430.6M
Short-Term Investments $903.9M $943.1M $904.6M $914.2M $940.6M $943.6M $940.4M $594.6M
Cash & Short-Term Investments $945.7M $970.9M $956.4M $966.6M $989.0M $996.0M $1.01B $1.03B
Accounts Receivable, Net $411K $149K $35.00M $0 -- -- -- --
Total Current Assets $959.4M $983.3M $1.00B $975.9M $998.1M $1.01B $1.02B $1.03B
Property, Plant & Equipment, Net $2.79M $3.26M $3.55M $3.85M $4.31M $4.69M $4.95M $4.86M
Other Non-Current Assets $3.89M $2.91M $3.94M $2.61M $2.63M $2.69M $2.79M $2.88M
Total Non-Current Assets $24.27M $24.32M $26.18M $25.68M $26.68M $26.66M $27.43M $27.85M
Total Assets $983.7M $1.01B $1.03B $1.00B $1.02B $1.03B $1.05B $1.06B
Accounts Payable $4.30M $3.02M $3.38M $4.97M $3.40M $3.48M $2.35M $4.03M
Deferred Revenue (Current) $27.22M $35.07M $37.59M $0 -- -- -- $0
Total Current Liabilities $54.25M $60.15M $58.91M $25.00M $27.83M $21.38M $17.50M $17.46M
Deferred Revenue (Non-Current) $50K $1.08M $8.68M $0 -- -- -- --
Total Non-Current Liabilities $17.80M $19.52M $27.77M $19.75M $20.38M $20.32M $20.80M $21.28M
Total Liabilities $72.04M $79.67M $86.69M $44.74M $48.21M $41.70M $38.30M $38.73M
Total Debt (incl. Leases) $20.38M $20.99M $21.57M $22.14M $22.66M $22.19M $22.61M $23.02M
Common Stock $61K $61K $60K $60K $60K $59K $59K $59K
Retained Earnings -$419.3M -$397.7M -$375.7M -$351.4M -$319.4M -$295.1M -$261.3M -$237.8M
Accumulated Other Comp. Income -$6.49M -$2.31M $576K $4.32M $4.56M $3.75M $3.76M $2.16M
Total Stockholders' Equity $911.6M $928.0M $941.5M $956.8M $976.6M $990.5M $1.01B $1.02B
Total Equity $911.6M $928.0M $941.5M $956.8M $976.6M $990.5M $1.01B $1.02B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$113.6M -$68.99M -$58.29M -$63.06M -$32.67M -$6.78M
Depreciation & Amortization $2.03M $2.06M $1.96M $841K $113K $13K
Stock-Based Compensation $40.22M $33.02M $20.00M $17.20M $6.91M $72K
Change in Receivables -- -- -- $0 $8.00M -$8.00M
Change in Payables $977K $1.58M $277K -$294K $2.14M $14K
Operating Cash Flow -$82.23M -$43.81M -$50.58M -$42.92M -$16.98M -$4.37M
Capital Expenditure -$1.04M -$359K -$1.85M -$6.45M -$1.48M $0
Free Cash Flow -$83.28M -$44.17M -$52.42M -$49.37M -$18.46M -$4.37M
Purchases of Investments -$705.2M -$470.6M -$317.3M -$294.4M -$473.6M $0
Investing Cash Flow -$301.0M -$258.0M -$41.19M $58.27M -$341.0M $0
Financing Cash Flow $4.95M $713.2M $59.55M $500K $386.5M $11.52M
Net Change in Cash -$378.3M $411.4M -$32.22M $15.84M $28.59M $7.16M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.57M -$21.97M -$24.36M -$31.95M -$24.31M -$33.86M -$23.51M -$20.22M
Depreciation & Amortization $458K $463K $469K $468K $501K $541K $519K $512K
Stock-Based Compensation $8.54M $9.06M $9.27M $9.52M $9.04M $10.96M $10.70M $6.25M
Change in Receivables -$262K $34.85M -$35.00M -- $0 $0 $0 --
Change in Payables $1.28M -$342K -$1.61M $1.67M -$168K $1.11M -$1.64M $1.56M
Operating Cash Flow -$25.18M $12.48M -$12.34M -$28.54M -$12.86M -$23.81M -$17.02M -$16.73M
Capital Expenditure -$2.0K -$202K -$273K -$106K -$93K -$473K -$371K -$42K
Free Cash Flow -$25.18M $12.28M -$12.61M -$28.65M -$12.95M -$24.29M -$17.39M -$16.77M
Purchases of Investments -$76.50M -$144.8M -$112.8M -$123.3M -$118.0M -$92.69M -$371.3M -$24.03M
Investing Cash Flow $38.38M -$38.78M $8.29M $29.54M $8.31M $1.56M -$340.4M $33.93M
Financing Cash Flow $852K $2.24M $3.54M $2.94M $493K $954K $554K $386.6M
Net Change in Cash $14.05M -$24.06M -$506K $3.94M -$4.06M -$21.30M -$356.9M $403.9M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1576.7% -933.6% -902.9% -779.0% -905.4% --
Net Profit Margin -1136.2% -651.6% -721.2% -732.2% -898.3% --
Return on Equity (ROE) -11.9% -6.7% -16.9% -19.7% -8.9% --
Return on Assets (ROA) -11.3% -6.5% -15.3% -17.3% -8.6% -41.8%
Current Ratio 39.04x 59.21x 26.80x 20.14x 29.46x 5.05x
Quick Ratio 38.67x 58.72x 26.40x 19.81x 29.30x 4.97x
Debt to Equity 0.02x 0.02x 0.07x 0.08x 0.00x --
Revenue Growth (YoY) -5.6% +31.0% -6.1% +136.8% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -599.3% -598.1% -1143.1% -1576.7% -1442.9% -33002.1% -1216.6% -933.6%
Net Profit Margin -428.7% -427.5% -833.6% -1136.2% -1019.0% -24064.0% -832.7% -651.6%
Return on Equity (ROE) -11.0% -11.1% -12.2% -11.9% -10.4% -10.7% -7.7% -6.7%
Return on Assets (ROA) -10.2% -10.2% -11.1% -11.3% -9.9% -10.2% -7.4% -6.5%
Current Ratio 17.69x 16.35x 17.01x 39.04x 35.86x 47.03x 58.47x 59.21x
Quick Ratio 17.44x 16.14x 16.83x 38.67x 35.54x 46.59x 57.94x 58.72x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.02x 0.02x 0.02x 0.02x
Revenue Growth (YoY) -7.1% -- -- -- +2177.9% -100.0% -100.0% -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001817713) · from June 30, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal